Armistice Capital »

Nuscale PWR Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Nuscale PWR Corp (SMR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nuscale PWR Corp

Tip: Access up to 7 years of quarterly data

All positions including Nuscale PWR Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuscale PWR Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $459k 46k 10.03

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Nuscale PWR Corp

Van Eck Associates Corp.
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Marex Group
Mirae Asset Global Etfs Holdings
Two Sigma Investments
Susquehanna International
Jane Street
Morgan Stanley
Geode Capital Management
Citadel Advisors
Goldman Sachs Group
UBS Group
State Street Corporation

View all funds holding Nuscale PWR Corp